A story in MODERN HEALTHCARE's "For the Record" section (Feb. 19, p. 14) gives readers a false and misleading impression of ChoiceCare.
Contrary to what the story states, our treatment guideline for urinary-tract infections is still in place. It is sound medicine. It has not been rescinded or "dropped" as a result of physician reaction.
ChoiceCare's decision to work with Procter & Gamble on a protocol designed to help physicians treat urinary-tract infections was in no way influenced by the fact we provide healthcare benefits to P&G's employees and their families.
The protocol was evaluated, modified and approved by a committee that includes seven independent physicians who participate on ChoiceCare panels.
When we develop or implement any program, our goal is to improve the quality of care our enrollees receive by providing physicians with information on the most effective treatment options. In most cases, the consistent implementation of the most effective options also results in lower costs.
DANIEL A. GREGORIE, M.D.
President, chief executive officer